This company has been marked as potentially delisted and may not be actively trading. NYSE:NHWK NightHawk Biosciences (NHWK) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About NightHawk Biosciences Stock (NYSE:NHWK) 30 days 90 days 365 days Advanced Chart Get NightHawk Biosciences alerts:Sign Up Key Stats Today's Range N/A50-Day Range$0.26▼$0.5052-Week Range N/AVolume173,100 shsAverage Volume97,242 shsMarket Capitalization$10.78 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM (obiltoxaximab), a monoclonal antibody antitoxin for the treatment of inhalational anthrax. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.Read More… Receive NHWK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NightHawk Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address NHWK Stock News HeadlinesSCPXD Scorpius Holdings, Inc.July 21, 2024 | seekingalpha.comScorpius Holdings GAAP EPS of -$1.74April 29, 2024 | seekingalpha.comWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.May 2, 2025 | Altimetry (Ad)Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major UniversityMarch 19, 2024 | globenewswire.comScorpius Holdings Accepted as a Member of the US Government's BioMaP-ConsortiumMarch 14, 2024 | globenewswire.comScorpius Holdings, Inc. Announces Closing of Public OfferingMarch 12, 2024 | globenewswire.comScorpius Holdings, Inc. Announces Pricing of Public OfferingMarch 8, 2024 | globenewswire.comScorpius Holdings, Inc. Announces Proposed Public Offering of Common StockMarch 7, 2024 | globenewswire.comSee More Headlines NHWK Stock Analysis - Frequently Asked Questions How were NightHawk Biosciences' earnings last quarter? NightHawk Biosciences, Inc. (NYSE:NHWK) released its earnings results on Tuesday, November, 9th. The biopharmaceutical company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.29) by $0.01. The biopharmaceutical company earned $0.50 million during the quarter, compared to analysts' expectations of $0.57 million. NightHawk Biosciences had a negative trailing twelve-month return on equity of 91.62% and a negative net margin of 2,333.27%. When did NightHawk Biosciences' stock split? NightHawk Biosciences shares reverse split on the morning of Friday, December 11th 2020. The 1-7 reverse split was announced on Thursday, December 10th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. What other stocks do shareholders of NightHawk Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that NightHawk Biosciences investors own include Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Meta Platforms (META), Vaxart (VXRT), Alibaba Group (BABA), NVIDIA (NVDA) and Novavax (NVAX). Company Calendar Last Earnings11/09/2021Today5/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNYSE:NHWK CIK1476963 Webwww.nighthawkbio.com Phone919-240-7133FaxN/AEmployees77Year Founded2008Profitability EPS (Most Recent Fiscal Year)($1.99) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-43,440,000.00 Net Margins-2,333.27% Pretax Margin-2,546.97% Return on Equity-91.62% Return on Assets-56.48% Debt Debt-to-Equity Ratio0.27 Current Ratio0.99 Quick Ratio0.99 Sales & Book Value Annual Sales$6.38 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$2.82 per share Price / BookN/AMiscellaneous Outstanding Shares26,080,000Free Float21,935,000Market Cap$10.78 million OptionableOptionable Beta0.19 Social Links 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NYSE:NHWK) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NightHawk Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NightHawk Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.